We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program

News   Aug 06, 2015

 
MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program
 
 
Advertisement
 

RELATED ARTICLES

Peptide Combo Could Help Reduce Damage Caused By SARS-CoV-2

News

Two peptides once combined, work together to penetrate cells' membranes in order to dampen an acute inflammatory response. In this first ex vivo study, the peptide reduced collagen degradation. The researchers say the peptide could alleviate some of the worst damage caused by acute inflammatory responses.

READ MORE

Switching Immune Cells From “Protect” to “Attack” Mode To Treat Prostate Cancer

News

Researchers found that immune cells called macrophages, which are typically found in prostate cancer tumors to help promote growth, can be rewired to attack the disease using therapeutics.

READ MORE

Key Protein Behind Cancer Relapse and Progression Uncovered

News

Researchers have discovered a mechanism involving the MBNL1 protein that predicts several characteristics of cancer including progression and relapse.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE